Lesson 5 of 5 / Enzymes and investigations
Allosteric enzymes and end-product inhibition
How can the end product of a pathway switch off its own production?
I can explain cooperative binding in allosteric enzymes, allosteric inhibition and end-product inhibition.
I can explain competitive, non-competitive and allosteric inhibition.Syllabus
Syllabus 9477, Core 1(s). Explain competitive, non-competitive and allosteric inhibition.
About 6 min
Make a guess. You are not marked.
A cell is making far more of a product than it needs. Which molecule is best placed to slow the first enzyme of the pathway?
Show the answer
The final product of the pathway itself.
The more product builds up, the more it inhibits the first enzyme. Production slows until the product is used up.
The key idea
An allosteric enzyme has several subunits that bind substrate cooperatively, so its rate curve is sigmoid. In end-product inhibition, the last product of a pathway binds an allosteric site on an early enzyme and slows its own production.
Explore the idea
An S-shaped curve, shifted by the end product
Green: the allosteric enzyme gives a sigmoid curve, because its subunits bind substrate cooperatively. Grey, dashed: a one-site enzyme rises steeply from the start.
Original illustrative models. Real inhibitors differ in how far they shift the curve.
Explanation
An allosteric enzyme usually has several subunits. A subunit is one polypeptide chain in a protein made of several chains. Each subunit has its own active site. The enzyme also has allosteric sites: binding sites away from the active site, where regulator molecules bind.
When a substrate molecule binds to one subunit, that subunit changes shape. The change spreads to the other subunits, so their active sites bind substrate more easily. This is cooperative binding. It makes a graph of rate against substrate concentration sigmoid, or S-shaped. The rate rises slowly at low substrate, then steeply, then levels off.
An allosteric inhibitor binds at an allosteric site. It holds the enzyme in its less active shape, so the active sites bind substrate less readily. The sigmoid curve shifts to the right, and the rate at each substrate concentration is lower.
A metabolic pathway is a chain of reactions, each catalysed by its own enzyme. In end-product inhibition, the final product of a pathway is an allosteric inhibitor of an enzyme near its start. When the product builds up, it slows its own production. When it is used up, it leaves the allosteric site, and the pathway speeds up again. This is negative feedback: a change sets off a response that reverses it.
For example, ATP inhibits phosphofructokinase, an enzyme early in glycolysis. A cell with plenty of ATP breaks down less glucose. Examiners report that very few candidates mentioned end-product inhibition or negative feedback when a question needed them.
Step by step
- 1
Count the subunits
Several subunits, each with an active site, allow cooperative binding.
- 2
Read the curve shape
Sigmoid: slow, then steep, then level. A one-site enzyme rises steeply from the start.
- 3
Trace the feedback
More end product means more inhibition, so less end product is made.
Worked example
Work through the evidence
Invented data: an allosteric enzyme was given substrate at 5, 10, 20, 40 and 80 units. Its rates were 2, 6, 30, 80 and 95 units. Describe and explain the shape of the curve.
One way to explain it
The rate rises slowly, from 2 to 6 units, between 5 and 10 units of substrate. It then rises steeply to 80 units at 40, and levels off near 95. At low substrate, few subunits have bound substrate. Each binding makes the other subunits bind more easily, so the rate climbs steeply: cooperative binding. At high substrate, nearly every active site is occupied.
Why this answer works
- Describe the pattern with figures before explaining it.
- Link the steep middle section to cooperative binding.
Watch out for this
A student says: "End-product inhibition makes a cell build up more of the end product." What is wrong with this?
Show the answer
The end product slows an early enzyme, so less end product is made. Its level falls back towards what the cell needs.
In the real world
ATCase in E. coli
In the bacterium E. coli, the enzyme ATCase catalyses the first step in making pyrimidine nucleotides. It has 12 subunits. CTP, the end product of the pathway, binds to its regulatory subunits and slows it down.
Check your understanding
In a pathway, the end product Z is an allosteric inhibitor of the first enzyme. The cell rapidly uses up its Z. What happens next?
Show the answer
Z leaves the enzyme, so the pathway speeds up and makes more Z.
Less Z means less inhibition, so the first enzyme returns to its more active shape.
Quick recall
How can the end product of a pathway switch off its own production?